Effect of screening and adjuvant therapy on mortality from breast cancer

By Kathleen A. Cronin, Sylvia K. Plevritis, Dennis G. Fryback. 2005

1,296 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/641bc7d77792706cd3bb610dd7edf40d06ae34d4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. R. Siegel
2. A. Jemal
3. C. DeSantis
4. Elizabeth E. Ward
5. S. Fedewa
6. Douglas G. Altman
7. A. Mariotto
8. K. Miller

In Pathology and Forensic Medicine

1. Douglas G. Altman
2. A. Jemal
3. R. Siegel

Citations in the corpus

• Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study (2006, background): “11 121 (1) 109 519 (14) Referent – Referent – Referent – 254 (2) 2 583 (18) Referent – Referent – Referent –”
• Cancer treatment and survivorship statistics, 2012 (2012, background): “This increase is due largely to improvements in treatment (ie, chemotherapy and hormone therapy) and to earlier diagnosis resulting from the widespread use of mammography.(22) The 5-year relative survival rate for women diagnosed with localized breast cancer is 98.”
• The benefits and harms of breast cancer screening: an independent review (2013, positive): “Improvements in treatment and service delivery are likely to have made the largest contribution to decreased mortality (Berry et al, 2005).”